ICU MEDICAL INC/DE (ICUI) Gross Margin
- Gross margin · 12 months: Value 39.13%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 39.13% | Gross profit / revenue. Period ending 2026-06-30. $845.14M ÷ $2.16B × 100 ≈ 39.13% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 845.14M USD | Gross Profit |
| Revenue | 2.16B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $845.14M | $2.16B | (m) | 39.13% |
| 2026-03-31 | $818.16M | $2.16B | (m) | 37.93% |
| 2025-12-31 | $822.04M | $2.23B | $1.41B | 36.84% |
| 2025-09-30 | $846.31M | $2.32B | (m) | 36.47% |
| 2025-06-30 | $850.28M | $2.37B | (m) | 35.84% |
| 2025-03-31 | $849.65M | $2.42B | (m) | 35.11% |
| 2024-12-31 | $824.78M | $2.38B | $1.56B | 34.62% |
| 2024-09-30 | $769.11M | $2.34B | (m) | 32.87% |
| 2024-06-30 | $748.18M | $2.30B | (m) | 32.47% |
| 2024-03-31 | $733.08M | $2.26B | (m) | 32.48% |
| 2023-12-31 | $739.87M | $2.26B | $1.52B | 32.75% |
| 2023-09-30 | $743.23M | $2.25B | (m) | 33.04% |
| 2023-06-30 | $745.71M | $2.29B | (m) | 32.51% |
| 2023-03-31 | $720.98M | $2.31B | (m) | 31.27% |
| 2022-12-31 | $697.76M | $2.28B | $1.58B | 30.60% |
| 2022-09-30 | $650.31M | $2.04B | (m) | 31.84% |
| 2022-06-30 | $591.70M | $1.78B | (m) | 33.23% |
| 2022-03-31 | $547.64M | $1.54B | (m) | 35.53% |
| 2021-12-31 | $491.49M | $1.32B | $824.82M | 37.34% |
| 2021-09-30 | $483.87M | $1.30B | (m) | 37.33% |
| 2021-06-30 | $470.01M | $1.28B | (m) | 36.76% |
| 2021-03-31 | $452.76M | $1.26B | (m) | 35.92% |
| 2020-12-31 | $461.50M | $1.27B | $809.51M | 36.31% |
| 2020-09-30 | $455.76M | $1.27B | (m) | 36.00% |
| 2020-06-30 | $460.39M | $1.25B | (m) | 36.69% |
| 2020-03-31 | $457.98M | $1.26B | (m) | 36.24% |
| 2019-12-31 | $471.86M | $1.27B | $794.34M | 37.27% |
| 2019-09-30 | $492.36M | $1.29B | (m) | 38.14% |
| 2019-06-30 | $508.40M | $1.31B | (m) | 38.79% |
| 2019-03-31 | $556.33M | $1.36B | (m) | 40.94% |
| 2018-12-31 | $570.03M | $1.40B | $830.01M | 40.72% |
| 2018-09-30 | $572.88M | $1.43B | (m) | 40.07% |
| 2018-06-30 | $549.89M | $1.45B | (m) | 38.03% |
| 2018-03-31 | $486.15M | $1.42B | (m) | 34.31% |
| 2017-12-31 | $426.10M | $1.29B | (m) | 32.96% |
| 2017-09-30 | $339.37M | $1.02B | (m) | 33.33% |
| 2017-06-30 | $279.04M | $772.05M | (m) | 36.14% |
| 2017-03-31 | $241.11M | $537.26M | (m) | 44.88% |
| 2016-12-31 | $201.40M | $379.37M | (m) | 53.09% |
| 2016-09-30 | $198.90M | $374.07M | (m) | 53.17% |
| 2016-06-30 | $193.89M | $362.98M | (m) | 53.42% |
| 2016-03-31 | $187.52M | $350.04M | (m) | 53.57% |
| 2015-12-31 | $180.80M | $341.67M | (m) | 52.92% |
| 2015-09-30 | $172.22M | $331.18M | (m) | 52.00% |
| 2015-06-30 | $164.11M | $322.62M | (m) | 50.87% |
| 2015-03-31 | $157.89M | $317.51M | (m) | 49.73% |
| 2014-12-31 | $151.40M | $309.26M | (m) | 48.96% |
| 2014-09-30 | $150.66M | $307.31M | (m) | 49.03% |
| 2014-06-30 | $153.47M | $312.66M | (m) | 49.08% |
| 2014-03-31 | $153.97M | $312.65M | (m) | 49.25% |
| 2013-12-31 | $154.73M | $313.72M | (m) | 49.32% |
| 2013-09-30 | $157.56M | $318.45M | (m) | 49.48% |
| 2013-06-30 | $157.29M | $317.04M | (m) | 49.61% |
| 2013-03-31 | $158.34M | $315.66M | (m) | 50.16% |
| 2012-12-31 | $156.51M | $316.87M | (m) | 49.39% |
| 2012-09-30 | $150.69M | $310.67M | (m) | 48.51% |
| 2012-06-30 | $145.57M | $305.72M | (m) | 47.62% |
| 2012-03-31 | $142.69M | $306.24M | (m) | 46.60% |
| 2011-12-31 | $142.35M | $302.19M | (m) | 47.11% |
| 2011-09-30 | $143.91M | $301.35M | (m) | 47.76% |
| 2011-06-30 | $142.37M | $300.62M | (m) | 47.36% |
| 2011-03-31 | $138.29M | $291.69M | (m) | 47.41% |
| 2010-12-31 | $130.59M | $284.58M | (m) | 45.89% |
| 2010-09-30 | $124.50M | $278.78M | (m) | 44.66% |
| 2010-06-30 | $115.52M | $257.00M | (m) | 44.95% |
| 2010-03-31 | $109.18M | $241.54M | (m) | 45.20% |
| 2009-12-31 | $108.82M | $231.51M | (m) | 47.00% |
| 2009-09-30 | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) |
| 2008-12-31 | $89.82M | $204.73M | (m) | 43.87% |
| 2008-09-30 | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) |
| 2008-03-31 | (m) | (m) | (m) | (m) |
| 2007-12-31 | $78.24M | $188.14M | (m) | 41.59% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |